Funded Tech Companies
Athira Pharma
Looking for the VC firms that provided funding to Athira Pharma? Avidity Partners, Highside Capital Management and Venrock invested in this biopharmaceutical company.
Company Overview
Company Name
Athira Pharma
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
4000 Mason Rd. 300 Box 352141
Seattle, WA 98195
USA
Seattle, WA 98195
USA
Phone
Website
Email Address
Company Background Information
Overview
Athira Pharma (Nasdaq: ATHA) is a drug development company striving to improve human health by advancing new therapies for neurodegenerative diseases like Alzheimer's and Parkinson's. Our innovative approach is focused on turning brain degeneration into regeneration, achieved by re-establishing lost connections and restoring lost function.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/17/2020
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Leen Kawas
Chief Financial Officer
Glenna Mileson
Chief Operating Officer
Mark Litton
VP - Bus. Development
Josh Pan
VP - General Counsel
Christina Thomson
VP - R & D
Xue Hua
Company Investors
- Avidity Partners
- Highside Capital Management
- Venrock
- Rock Springs Capital
- Logos Capital
- Sofinnova Ventures
- RTW Investments
- Sahsen Ventures
- LifeSci Venture Partners
- Viking Global Investors
- Perceptive Advisors (Joseph Edelman)
- Janus Henderson Investors
- Franklin Templeton
- Surveyor Capital
- Private Investors (Rick Kayne)
- Private Investors (Suzanne Kayne)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs